Positive Efficacy Data from ALLOB Phase IIA Spinal Fusion Trial

Results from the first half of patients in a Phase IIA spinal fusion trial with Bone Therapeutics' ALLOB® show evidence of successful fusion and clinical improvements in function and pain at 6 months. All patients reached primary and secondary endpoints at 12-month follow-up.

Specifically, fusion was observed in 6 of 8 patients at 6 months and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0